0
Startups & Venture·November 11, 2026·1 min read

Colossal Biosciences Backer 81 Collection Raises Second Fund

Share

An $82m second fund from 81 Collection — backing companies like Colossal — is more capital flowing into speculative bio and deep tech bets. If you’re building in that zone, expect investors to push harder on platform narratives and IP moats, not just single-asset upside.